Congress is finally taking on the middlemen driving up your drug costs

You deserve to know why this is happening and who is benefiting from it.

The answer: We are paying the price for PBM greed.

Since 2021, the House Committee on Oversight and Government Reform has investigated pharmacy benefit managers, commonly known as PBMs. PBMs operate as middlemen in the prescription drug market, negotiating with drug manufacturers,continue reading …